Primary carcinoma of the cystic duct: a case report and review of classifications by unknown
CASE REPORT Open Access
Primary carcinoma of the cystic duct: a
case report and review of classifications
Lovenish Bains1*, Daljit Kaur2, Arun Kumar Kakar1, Aman Batish1 and Seema Rao3
Abstract
Background: The incidence of extrahepatic bile duct malignancies is about 2–3.6% of all gastrointestinal malignancies.
Primary carcinoma of cystic duct is a rare condition comprising a fraction of all extrahepatic bile duct malignancies
with less than 70 cases reported worldwide. Majority of these cases were reported from East Asia. There is paucity in
such case being reported from Indian subcontinent. We present a case of primary carcinoma of the cystic duct
encountered during laparoscopic cholecystectomy.
Case presentation: A 65-year-old lady presented to us with symptomatic gall stone disease. Investigations revealed a
distended gall bladder with multiple stones. Patient was taken up for laparoscopic cholecystectomy, during surgery a
stony hard structure was found at cystic duct-common bile duct junction which was not amenable for clear dissection.
Procedure was converted to open, and the patient underwent cholecystectomy with resection of common bile duct
with Roux-en-Y hepaticojejunostomy and regional lymphadenectomy. Histopathological findings revealed it to be
moderately differentiated adenocarcinoma of the cystic duct.
Conclusion: Primary carcinoma of cystic duct is a rare condition where early diagnosis can be difficult and
if accidentally detected may add to surgeon’s dilemma. Proper surgery with en-bloc resection of gallbladder,
cystic duct, common bile duct, and regional lymphadenectomy is the mainstay of treatment. The prognosis
of carcinoma of cystic duct is better than extrahepatic bile duct malignancies. The old classification system
has outlived its time and is more rigid in definition which is not practical in advanced cases; the new
classification systems of this century offer better insight into understanding the tumor characteristics
and prognosis.
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Background
The incidence of extrahepatic bile duct malignancies
is about 2–3.6% of all gastrointestinal malignancies.
Primary carcinoma of cystic duct is a rare condition
comprising a fraction of all extrahepatic bile duct
malignancies with less than 70 cases reported world-
wide. Majority of these cases were reported from East
Asia, there is paucity in such case being reported
from Indian subcontinent. It is difficult to implement
strict criteria of Farrar [1] viz. (i) growth restricted
to the cystic duct, (ii) absence of neoplastic process
in the gall bladder, hepatic, or common bile duct,
(iii) histological evidence of carcinoma; to all cases as
majority of cases reported were advanced. Early diag-
nosis can be difficult and if accidentally detected may
add to surgeon’s dilemma. Prompt surgery with en
bloc resection of gallbladder, cystic duct, common bile
duct, and regional lymphadenectomy is the mainstay of
treatment. Adenocarcinoma is the predominant pattern;
however, small cell carcinoma, carcinoid tumor, mucin-
producing carcinoma also have been reported. The old
classification system of Farrar [1] may not fit the current
scenario due to its strict definition whereas the new
classification systems [2–5] attempt to cover those
shortcomings and highlight biological behaviour of
this tumor.
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Case presentation
A 65-year-old female presented to surgery outpatient
department for recurrent right upper abdominal pain for
last 3 months. There was an episode of jaundice
2 months back, which subsided spontaneously in a week.
General physical examination and abdominal examin-
ation were essentially normal. Ultrasonography showed
gall bladder distended (150 × 54 mm) with multiple
small stones (ranging 2–5 mm), common bile duct
8 mm, no mass or lymph nodes. Investigations and
laboratory parameters including liver function tests were
within normal range. Magnetic resonance imaging was
performed in view recent episode of jaundice which re-
vealed mucocele of GB and no other significant findings.
(Figs. 1 and 2) Patient was taken up for elective laparo-
scopic cholecystectomy. During surgery, a hard structure
(stone/node) was found at cystic duct-common bile duct
junction which was not amenable for clear dissection.
The procedure was converted to open, the structure was
palpated to be stony hard (adherent lymph node). No
other mass or lymph nodes were noticed. The patient
underwent extended cholecystectomy with resection of
CBD with Roux-en-Y hepaticojejunostomy with regional
lymphadenectomy. The patient made uneventful recov-
ery and is doing well after 1.5 years of surgery.
On section cystic duct showed a polypoidal, solid
growth measuring 2×1.5×1.0 cm in size and projecting
into the lumen of CBD. Histological examination of the
growth revealed moderately differentiated adenocarcin-
oma arising from duct epithelium and protruding in the
lumen (Fig. 3). Tumor showed moderate pleomorphism,
focal papillary pattern and high mitotic activity and was
infiltrating full thickness of the duct wall and reaching
up to serosa (Fig. 4). It showed perineural invasion but
no lymph node metastasis. The resected margins were
clear. Gall bladder was consistent with chronic chole-
cystitis with mucosal ulceration, focal xanthogranuloma-
tous inflammation.
Discussion
Primary carcinoma of the extrahepatic biliary tree has an
incidence of 0.14% of all malignancies with commonest site
as the CBD (40.1%) whereas primary carcinoma of cystic
duct is extremely rare [5, 6]. The incidence of primary
carcinoma of cystic duct in autopsy studies was found to
be 0.03–0.05% [7]. The primary carcinoma of cystic duct
has been found to have male preponderance with no spe-
cific sex predilection and the average age of presentation
was 65 years (range, 38–79 years) [2, 4–6, 8, 9] Gallstones
are not associated with all cases, being found in about 25%
of the cases [2, 5, 10], and 48 and 37% in two other
series [2, 9] which is in stark contrast to 75–90% re-
ported for classical gall bladder carcinoma. It is proved
that inflammation of the biliary duct epithelium due to
Fig. 1 MRI showing mucocele of gall bladder (coronal plane)
Fig. 2 MRI showing mucocele of gall bladder (transverse plane)
Fig. 3 Adenocarcinoma protruding in the lumen
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irritation from reflux and stasis of pancreatic juice and bile
leads to malignancy over a period of time [2, 7, 10, 11].
However, the risk factors for carcinoma of cystic duct are
unclear.
Its clinical presentation is non-specific and mostly is
similar to biliary calculus disease [2, 6, 7, 11]. The
symptoms may develop earlier than GB cancer. The
main symptom was abdominal pain and jaundice, both
being equally distributed [1, 2, 4, 5, 8] According to
Baraka et al. in 33 reported cases 81% presented with
right upper quadrant abdominal pain, 41% with abdom-
inal mass, and four cases with obstructive jaundice [6].
Gallbladder was found to be hydropic in 86 and 93%
cases [2, 5]. The tumour is either discovered at laparot-
omy or on histopathological examination of the speci-
men [1, 2, 4–6, 11]. In none of the cases reported, a
preoperative diagnosis was made. In our case too,
patient had history of transient jaundice with upper
abdominal pain and hydrops of gallbladder and final
diagnosis was made on histopathological examination.
Neoplasm of the cystic duct can be suspected in pa-
tients presenting with distended gallbladder likely due
to cystic duct obstruction without evidence of stone
impaction in the cystic duct.
Different staging systems for various cancer have been
described worldwide but to date no diagnostic or staging
system have been established for carcinoma of cystic
duct which could be uniform and applicable to all cases
[1–5]. In 1951, Farrar’s first described diagnostic criteria
for primary carcinoma of cystic duct [1] (Table 1).
Farrar criteria is strict and cannot differentiate
advanced tumors as patients may present in different
stages of the disease and true cystic duct carcinoma
becomes a non-cystic duct carcinoma once it ad-
vanced beyond cystic duct [1, 2]. The new classifica-
tion(s) [3–5] that defines carcinoma of cystic duct as
a tumor with its center located in the cystic duct
appears more practical as mostly reported cases of
carcinoma of cystic duct were advanced. The cystic
duct is a short structure, which lacks a proper muscle
layer and consists of a thin fibro-muscular layer and
adventitia. Extra hepatic bile ducts are lined by a
layer of tall columnar epithelium which extends from
the mucosal lining through the entire wall to form
glands in the outer coats of the ducts. Thin-walled
ducts, the presence of glands in the outer coats, the
rich lymphatic network and nerve supply apparently
facilitate spread of the tumor to periductal structures
[12]. The histology of the cystic duct comprises a
transient pattern from gallbladder to bile duct, indi-
cating that there is a watershed in the cystic duct that
separates the features of the gallbladder from those of
the bile duct [4].
The classically described carcinoma of cystic duct is
very rare and is attributed to its strict definition [1] in
which a tumor is restricted to the cystic duct, and if new
definitions [3–5] are properly applied then more cases
can come up. Most of the tumors were microscopically
well-differentiated adenocarcinoma, but small cell
carcinoma, carcinoid tumor, mucin-producing carcin-
oma of cystic duct also have been reported [3, 9, 13].
Bile duct invasion is relatively rare [1, 11, 14, 15].
The incidence of lymph node metastasis is (0–40%)
in patients with carcinoma of cystic duct which is
lower than those with extrahepatic bile duct (about
50%) or GB cancer (40–80%) [2, 4, 11, 15].
The early development of symptoms due to obstruc-
tion of the cystic duct, mimicking signs and symptoms
of gallbladder disease, slow growth, and late metastasis
favor a better prognosis in patients with carcinoma of
cystic duct as compared to extrahepatic bile duct or GB
cancer [2–4, 6, 9, 11, 14, 15]. The perineural invasion is
one of the most significant prognostic risk factor in
malignancies of biliary tree. The incidence of perineural
invasion in extrahepatic bile duct carcinoma is 85–93%
and in gallbladder carcinoma is 24–72% [16]. High
frequencies of perineural (87%) and lymphatic invasion
(83.8%) were observed by Ozden et al., and similar find-
ings were reported by Nakata et al. as perineural
(73.3%) and lymphatic invasion (80%) [2, 5]. Perineural
and the microscopic vascular invasion were more fre-
quent in the HH type than in the CC type whereas
lymph node metastasis and lymphatic permeation was
similar in both [4].
In our case, the tumor was type 1 of Kim’s classification
(confined within the cystic duct), CC type of Yokohama’s
classification (in cystic duct and towards confluence of the
cystic duct) and type I of Nakata’s classification (located
wholly within the cystic duct). A meta-analysis conducted
by Kim et al. of the previous case reports regarding clinical
and pathological characteristics and patient survival found
that patients with type I cancer had significantly longer
Fig. 4 Tumor showing pleomorphism and high mitotic activity
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survival compared to type II or III cancer (p = 0.018,
p = 0.03). However, there was no significant difference
between patients with type II cancer and type III
cancer (p = 0.989) [3]. The survival rate tends to be
higher for patients with the CC type than for those
with the HH type (p = 0.064). The CC type lesions
were more common in males, and female sex was
predominant for the HH type [4]. It is concluded that
carcinomas of cystic duct extending beyond the cystic
duct are more aggressive and associated with a poorer
prognosis [4, 15].
The recommended treatment is radical surgery
comprising of cholecystectomy with non-anatomical gall-
bladder fossa resection and excision of extrahepatic bile
duct with regional lymphadenectomy.3,5,9,10.11 The average
tumor size was 25–27 mm with range of 4–60 mm [2, 5].
Postoperative adjuvant radiation therapy can be consid-
ered in cases of advanced carcinoma of cystic duct par-
ticularly those with positive surgical margin [3, 9].
The average survival was reported to be 27.2 months
while that of gallbladder carcinoma was only 5.8 months
and of other extrahepatic biliary ducts 3.2-11.4 months
[3, 15]. Nakata et al. reported 5-year survival rate of 40%
and median survival of 2.4 years. The survival was
significantly longer in patients with type I as compared
to type IV (p=0.05) whereas no significant differences in
survival rate among patients with types II, III, and IV
cystic duct carcinoma were found [5]. The median
overall survivals for patients with HH type and CC type
were 11.9 and 45.8 months, respectively [3]. Advances in
imaging and molecular basis of disease have led to better
understanding of this tumor however more number of
cases evaluation will provide significance.
Conclusion
This is a rare case of primary carcinoma of cystic duct
encountered during laparoscopic cholecystectomy in a
65-year-old lady. The patient underwent en-bloc resec-
tion of gallbladder, cystic duct, common bile duct, and
regional lymphadenectomy which remains the surgical
standard of treatment. Cystic duct carcinoma may be
overlooked in a patient with gallstones and hydropic
gallbladder. Primary carcinoma of cystic duct, albeit
rarely can be suspected in patients with distended gall
Table 1 Overview of various classifications [1–5]
Classification Current status
Farrar [1] (1951) (i) Growth restricted to the cystic duct
(ii) Absence of neoplastic process in the GB,
hepatic, or CBD
(iii) Histological evidence of carcinoma
-1st classification system but unsuitable in current
scenario where advanced cases are being detected
invading surrounding structures.
-No mention about lymph node metastasis
Ozden et al. [2] (2003) working definition of carcinoma of cystic duct is
a GB tumor
whose centre is located in the cystic duct
(the geometric centre of the tumor)
-Practical to determine geometric centre during
grossing however still may be difficult to label as
cystic duct carcinoma if it had been unequal growth
in different directions.
-It was based on assumption that the tumor grows
equally in all directions, which may not hold true for
all cases.
Kim et al. [3] (2007) (i) Type I-carcinoma confined within the cystic duct
(ii) Type II-carcinoma extended to the GB neck and
infundibulum or bile duct of cystic duct side without
obstructive jaundice
(iii) Type III-carcinoma extended up to the GB body
or bile duct on the contralateral side of cystic duct
opening which then causes obstructive jaundice
[centre located in the cystic duct]
-Based on the extent of tumor infiltration and such
classification defines treatment plan and improves
resectability.
Yokoyama et al. [4] (2008) A gallbladder tumor with centre of which is located in
the cystic duct:
(i) hepatic hilum type (HH)-tumor mainly invades the
hepatic hilum
(ii) cystic confluence type (CC)-tumor mainly involves
the confluence of the cystic duct
-HH type presentation, behaviour and prognosis
takes on the picture of gallbladder carcinoma,
whereas CC type takes on the picture of bile duct
carcinoma.
-This classification may be helpful for making a
diagnosis and planning the surgical procedure for
individual cystic duct carcinoma patients.
Nakata et al. [5] (2009) Based on extent of spread:
Type I-the tumor was located wholly within the cystic
duct
Type II-the tumor extended to the gallbladder
Type III-the tumor extended to the common hepatic
duct or the common bile duct (including extension into
the lumen and external invasion to the bile duct wall)
Type IV-the tumor extended to both the gallbladder and
the bile duct
-A high frequency of perineural infiltration and a
low frequency of hepatic infiltration result in cystic
duct carcinoma being a distinct entity from gallbladder
carcinoma and better prognosis than gallbladder
cancer and extra hepatic bile duct cancer.
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bladder where imaging studies have not clearly defined a
calculus. The prognosis of primary carcinoma of cystic
duct is better than other extrahepatic bile duct malignan-
cies. The old classification system has outlived its time
and is more rigid in definition which is not practical in
advanced cases; the new classification systems of this
century offer better insight into understanding the tumor
characteristics and prognosis. Further cases identified by
new systems may help in proper scientific interpretation
of the behavior of cystic duct carcinoma as a separate and
distinct identity and standardization of classification.
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